Thomas Helleday
Impact in
- Oncology top 0.05%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 0.2%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- DNA Repair Mechanisms 154
- CRISPR and Genetic Engineering 34
- Cancer therapeutics and mechanisms 27
- Biochemical and Molecular Research 19
- Oncology 103
- PARP inhibition in cancer therapy 55
- Cancer-related Molecular Pathways 26
- Co-authors
- Niklas Schultz (23 shared papers)Eva Petermann (12 shared papers)Helen E. Bryant (15 shared papers)Cecilia Lundin (17 shared papers)Mark Meuth (5 shared papers)Suzanne Kyle (3 shared papers)Huw D. Thomas (3 shared papers)Nicola J. Curtin (3 shared papers)
- Journals
- Nucleic Acids Research (16 papers)Cancer Research (16 papers)DNA repair (10 papers)Journal of Molecular Biology (8 papers)Molecular Cell (7 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Thomas Helleday
264 papers receiving 22.1k citations
Thomas Helleday's Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 9.6k
- Cancer Research 3.7k
- Molecular Biology 16.8k
- Cell Biology 1.6k
- Genetics 1.9k
Countries citing papers authored by Thomas Helleday
This map shows the geographic impact of Thomas Helleday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Helleday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Helleday more than expected).
Fields of papers citing papers by Thomas Helleday
This network shows the impact of papers produced by Thomas Helleday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Helleday. The network helps show where Thomas Helleday may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Helleday, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 264 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Hit paper breakdown → | 2005 | 3823 |
| 2 | DNA repair pathways as targets for cancer therapy Hit paper breakdown → | 2008 | 1317 |
| 3 | Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair Hit paper breakdown → | 2010 | 649 |
| 4 | The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings Hit paper breakdown → | 2011 | 615 |
| 5 | Mechanisms underlying mutational signatures in human cancers Hit paper breakdown → | 2014 | 558 |
| 6 | The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair Hit paper breakdown → | 2005 | 514 |
| 7 | 2009 | 483 | |
| 8 | 2007 | 465 | |
| 9 | 2005 | 433 | |
| 10 | 2018 | 363 | |
| 11 | 2010 | 362 | |
| 12 | 2005 | 359 | |
| 13 | 2013 | 355 | |
| 14 | 2014 | 344 | |
| 15 | 2001 | 325 | |
| 16 | 2014 | 301 | |
| 17 | 2010 | 281 | |
| 18 | 2012 | 276 | |
| 19 | 2005 | 272 | |
| 20 | 2003 | 250 |
About Thomas Helleday
Thomas Helleday is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Pulmonary and Respiratory Medicine, having authored 264 papers that have together received 22.3k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (154 papers), PARP inhibition in cancer therapy (55 papers), CRISPR and Genetic Engineering (34 papers), Carcinogens and Genotoxicity Assessment (28 papers), Cancer therapeutics and mechanisms (27 papers), Cancer-related Molecular Pathways (26 papers), Microtubule and mitosis dynamics (25 papers) and Biochemical and Molecular Research (19 papers). The work is most often cited by research in Oncology (9.6k citations), Cancer Research (3.7k citations), Molecular Biology (16.8k citations), Cell Biology (1.6k citations) and Genetics (1.9k citations). Thomas Helleday has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Niklas Schultz, Eva Petermann, Helen E. Bryant, Cecilia Lundin, Mark Meuth, Suzanne Kyle, Huw D. Thomas, Nicola J. Curtin, Elena López‐Knowles and Ricky A. Sharma. Their work appears in journals such as Nucleic Acids Research, Cancer Research, DNA repair, Journal of Molecular Biology and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.